These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8549289

  • 1. Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin.
    Bojar RA, Hittel N, Cunliffe WJ, Holland KT.
    Drugs; 1995; 49 Suppl 2():164-7. PubMed ID: 8549289
    [No Abstract] [Full Text] [Related]

  • 2. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.
    Tunca M, Akar A, Ozmen I, Erbil H.
    Int J Dermatol; 2010 Dec; 49(12):1440-4. PubMed ID: 21091683
    [Abstract] [Full Text] [Related]

  • 3. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
    Plewig G, Holland KT, Nenoff P.
    Eur J Dermatol; 2006 Dec; 16(1):48-55. PubMed ID: 16436342
    [Abstract] [Full Text] [Related]

  • 4. Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.
    Jacobs MR, Appelbaum PC.
    Expert Opin Pharmacother; 2006 Oct; 7(14):1957-66. PubMed ID: 17020421
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.
    Vogt K, Hahn H, Hermann J, Haustein UF, Blume U, Gollnick H, Orfanos CE.
    Drugs; 1995 Oct; 49 Suppl 2():266-8. PubMed ID: 8549327
    [No Abstract] [Full Text] [Related]

  • 6. Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents.
    Wilhelm KP, Wilhelm D, Neumeister C, Zsolt I, Schwantes U.
    Clin Exp Dermatol; 2012 Mar; 37(2):112-7. PubMed ID: 22103435
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S, Kurokawa I, Kawabata S.
    J Int Med Res; 1996 Mar; 24(6):473-7. PubMed ID: 8959531
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S, Sinha M, Saini S, Kaur SP, Gupta T, Sengupta S, Ghosh S, Sardana K.
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [Abstract] [Full Text] [Related]

  • 9. Activity of nadifloxacin and three other antimicrobial agents against Cutibacterium acnes isolated from patients with acne vulgaris.
    Nenoff P, Koch D, Krüger C, Neumeister C, Götz MR, Schwantes U, Bödeker RH, Borelli C.
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e682-e684. PubMed ID: 34018651
    [No Abstract] [Full Text] [Related]

  • 10. Should topical antibiotics be used for the treatment of acne vulgaris?
    Eady EA, Holland KT, Cunliffe WJ.
    Br J Dermatol; 1982 Aug; 107(2):235-46. PubMed ID: 6213256
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
    Kobayashi M, Nakagawa T, Fukamachi K, Nakamura M, Tokura Y.
    J Dermatol; 2011 Dec; 38(12):1163-6. PubMed ID: 22007904
    [Abstract] [Full Text] [Related]

  • 12. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
    Vogt K, Hermann J, Blume U, Gollnick H, Hahn H, Haustein UF, Orfanos CE.
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893
    [Abstract] [Full Text] [Related]

  • 13. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M.
    Skin Therapy Lett; 2010 Oct; 15(10):5-7. PubMed ID: 21076800
    [Abstract] [Full Text] [Related]

  • 14. Topical dilemmas in acne treatment.
    Lancet; 1982 Nov 20; 2(8308):1138-9. PubMed ID: 6128457
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients.
    Jung JY, Kwon HH, Yeom KB, Yoon MY, Suh DH.
    Int J Dermatol; 2011 Mar 20; 50(3):350-7. PubMed ID: 21342170
    [Abstract] [Full Text] [Related]

  • 16. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria.
    Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ.
    Br J Dermatol; 1996 Jan 20; 134(1):107-13. PubMed ID: 8745894
    [Abstract] [Full Text] [Related]

  • 17. Preparation, characterization, and in vitro antimicrobial assessment of nanocarrier based formulation of nadifloxacin for acne treatment.
    Kumar A, Agarwal SP, Ahuja A, Ali J, Choudhry R, Baboota S.
    Pharmazie; 2011 Feb 20; 66(2):111-4. PubMed ID: 21434572
    [Abstract] [Full Text] [Related]

  • 18. Topical antibacterial therapy for acne vulgaris.
    Dreno B.
    Drugs; 2004 Feb 20; 64(21):2389-97. PubMed ID: 15481998
    [Abstract] [Full Text] [Related]

  • 19. [Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne].
    Piérard GE.
    Rev Med Liege; 1997 Feb 20; 52(2):120-2. PubMed ID: 9173479
    [No Abstract] [Full Text] [Related]

  • 20. An overview of topical antibiotics for acne treatment.
    Toyoda M, Morohashi M.
    Dermatology; 1998 Feb 20; 196(1):130-4. PubMed ID: 9557247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.